Literature DB >> 28258032

Morbidity and mortality trends in very-very low birth weight premature infants in light of recent changes in obstetric care.

Péter Varga1, Botond Berecz1, Ákos Gasparics1, Zsófia Dombi1, Zsuzsa Varga1, Judit Jeager1, Zsófia Magyar1, János Rigó1, József Gábor Joó2, László Kornya3.   

Abstract

OBJECTIVE: In this study, we describe trends in morbidity and mortality of preterm infants with less than 500mg birth weight in the changing landscape of obstetric and neonatal care. STUDY
DESIGN: During a ten year study period between 2006 and 2016 we assessed outcome data for all neonates with less than 500mg birth weight born at our Neonatal Intensive Care Unit. We divided study subjects into two groups based on whether their birth date fell in the first half (2006-2010; n=39) versus the second half (2011-2015; n=27) of the study period comparing clinical outcomes in the two groups. We also assessed several clinical parameters for association with postnatal survival by comparing relative frequencies for each clinical parameter among surviving infants versus mortality cases.
RESULTS: Survival rate for preterm neonates with less than 500mg birth weight born between 2006 and 2010 was 30.8%. This survival rate rose to 70.4% in the second half of the study period between 2011 and 2015 (p<0.05). Among surviving babies premature birth was found to be predominantly associated with maternal hypertension or intrauterine growth restriction while in those who died premature birth due to premature rupture of membranes and spontaneous preterm labor were significantly more common. All surviving infants with less than 500mg birth weight were born via cesarean section whereas among those who died cesarean section had been performed in only 80% and vaginal delivery in 20% representing a significant difference between the groups (p<0.05). The majority (90.3%) of surviving infants with less than 500mg birth weight had received surfactant therapy while the proportion of neonates receiving surfactant therapy among mortality cases was significantly lower (65.2%; p<0.05). DISCUSSION: Our findings suggest that among premature neonates with less than 500mg birth weight preterm delivery due to premature rupture of membranes and intrauterine infections represents the worse mortality risk. Steroid prophylaxis and measures to prevent and treat intrauterine infections with appropriate use of antibiotics can markedly improve survival in these cases. In premature neonates with less than 500mg birth weight survival is more favorable after cesarean section compared to vaginal delivery.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  500mg birth weight; Antiobiotics treatment; Corticosteroid prophylaxis; Prematurity; Preterm birth; Survival

Mesh:

Year:  2017        PMID: 28258032     DOI: 10.1016/j.ejogrb.2017.01.051

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  4 in total

1.  Temporal Trends of Pediatric Dysphagia in Hospitalized Patients.

Authors:  Joshua Horton; Carlyn Atwood; Sharon Gnagi; Ronald Teufel; Clarice Clemmens
Journal:  Dysphagia       Date:  2018-02-20       Impact factor: 3.438

2.  Trends in Mortality and Morbidity in Infants Under 500 Grams Birthweight: Observations from Our Neonatal Intensive Care Unit (NICU).

Authors:  Péter Varga; Botond Berecz; Barbara Pete; Timea Kollár; Zsófia Magyar; Judit Jeager; Éva Romicsné Görbe; János Rigó; József Gábor Joó; Ákos Gasparics
Journal:  Med Sci Monit       Date:  2018-06-29

3.  Changes Overtime in Perinatal Management and Outcomes of Extremely Preterm Infants in One Tertiary Care Romanian Center.

Authors:  Diana Ungureanu; Nansi S Boghossian; Laura Mihaela Suciu
Journal:  Medicina (Kaunas)       Date:  2022-07-29       Impact factor: 2.948

4.  Incidence and Risk Factors Associated with Retinopathy of Prematurity in Peru.

Authors:  Carmen Sarita Carranza-Mendizabal; Mariela Diaz-Manrique; Percy G Ruiz Mamani; Michael White; Salomon Huancahuire-Vega
Journal:  Clin Ophthalmol       Date:  2021-05-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.